We have previously shown that transactivation by tumor suppressor protein p53 can be inhibited in vivo at elevated protein concentrations. In this study we characterize the structural requirements of this function. We show that oligomerization domain of p53 is involved in loss of transactivation at high protein concentrations: mutants not able to oligomerize are neither able to suppress transactivation, although these transactivating properties can be untouched.
Tumor suppressor protein p53 is involved in regulation of transcription activating the promoters located near to its DNA binding sites. Number of such genes are identi®ed, a part of them is clearly involved in regulation of cell proliferation (Barak et al., 1993; Buckbinder et al., 1995; El-Deiry et al., 1993; Kastan et al., 1992; Miyashita and Reed, 1995; Okamoto and Beach, 1994; Owen-Shaub et al., 1995) . p53 also represses many viral and cellular promoters Desaintes et al., 1995; Jackson et al., 1993; Subler et al., 1992 Subler et al., , 1994 . Exact mechanism of transrepression is obscure.
For transactivation, p53 must interact with the basal transcription machinery and bind sequence-speci®cally to DNA. The corresponding DNA sequence has been characterized having consensus 5'-RRRC(A/T)(A/ T)GYYYN 0 ± 13 RRRC(A/T)(A/T)GYYY-3' Funk, et al., 1992) .
Several functional domains on p53 amino acid chain have been characterized. The DNA binding domain of p53 is mapped between amino acids 102 and 290 (Bargonetti et al., 1993; Pavletich et al., 1993; Wang et al., 1993) . The N-terminal domain of p53 (amino acids 1 to 42) is needed for transactivation and it interacts with basal transcription factors. p53 protein is able to form tetramers in vivo, containing the oligomerization domain mapped between amino acids 323 and 355 (Clore et al., 1994; Wang et al., 1994) . Monomeric p53 retains transactivating ability (Crook et al., 1994; Pellegata et al., 1995; Sang et al., 1994; Tarunina and Jenkins, 1993; Wang et al., 1993) , but is incompetent for transrepression function (Crook et al., 1994; Pellegata et al., 1995; Sang et al., 1994) .
We have previously shown that at elevated expression conditions the transactivating property of wt p53 is strongly inhibited. In model systems, lower concentrations of p53 lead to activation of a promoter containing the consensus DNA binding site and higher concentrations to loss of this activity (Kristjuhan and Maimets, 1995) . The same phenomenon was also observed in cell lines where increase of endogenous p53 was induced with U.V. radiation (Lu et al., 1996) . In present study we show that oligomerization is necessary for`self-inhibition' of transactivation by p53.
To study the transactivation properties of p53 we used a set of p53 mutants in CAT assays ( Figure 1a) . Mutant DI has the ®rst evolutionary conserved domain of p53 deleted (Soussi et al., 1990) , but it behaves similarly to wt protein in transactivation, transrepression and growth suppression assays (Crook et al., 1994) . 1262 contains point mutations in Cterminus of protein disrupting p53 tetramers into monomers (StuÈ rzbecher et al., 1992; Tarunina and Jenkins, 1993) . Mutant D324 ± 355 has the oligomerization domain of p53 deleted. We controlled expression of proteins from our constructs in Saos2 cells, which do not contain endogenous p53 protein. All p53 proteins were expressed at comparable levels and immuno¯uorescent staining of transfected cells showed that all p53 proteins were located in the nucleus (data not shown).
The oligomerization domain of p53 is located between amino acids 323 and 355 (Clore et al., 1994; Wang et al., 1994) . Mutants D324 ± 355 and 1262 were expected to be monomers as D324 ± 355 has oligomerization domain deleted and 1262 contains four point mutations which abolish oligomerization of p53 (StuÈ rzbecher et al., 1992) . We determined the ability of p53 proteins to form homooligomers in vivo. Saos2 cells were transfected with p53 expression plasmids and lysed 24 h later in IP buer. Equal amounts of lysate were crosslinked with dierent concentrations of glutaraldehyde and p53 complexes were detected by Western blotting. As expected, mutant DI and wt protein can eciently form homodi-and tetramers in vivo, while D324 ± 355 and 1262 form monomers only (Figure 1b) .
To test the ability of p53 mutants to activate transcription at dierent concentrations, we cotransfected Saos2 cells with 1 mg of pBS-CON-CAT reporter plasmid and increasing amounts of p53 expression plasmids. Cells were collected and lysed 24 h after transfection. Before CAT reaction all lysates were normalized according to total amount of protein and eciency of transfection, thus every reaction contained the same amount of cells positive for p53 expression.
As expected, the highest activation of reporter gene by wt p53 was observed in transfections with relatively low concentration of expression plasmid (Figure 2a) , while increasing amounts of expression plasmid caused decrease in CAT activity.
MDM2 protein can inactivate transactivation capability of p53 interacting with transactivation domain of p53 and directing its degradation (Haupt et al., 1997; . Transcription of MDM2 gene is activated in p53 dependent manner (Barak et al., 1993) . Therefore it is possible that high expression of p53 protein causes accumulation of MDM2 protein, which in turn inactivates p53. To avoid eects of MDM2 protein we used the p53 DI mutant, which has MDM2 binding domain deleted and is resistant to MDM2-dependent inactivation and degradation . Deletion of the ®rst evolutionarily conserved domain of p53 caused decrease in the absolute level of reporter activation, but overall pattern of transactivation was the same: at higher amounts of expression plasmid the CAT activity was inhibited (Figure 2b ). At the same time activations of reporter gene by monomeric p53 mutants D324 ± 355 and 1262 were not inhibited at higher concentrations of expression plasmid and CAT activity reached to plateau (Figure 2c and d) . The loss of self-inhibition is likely to intrinsic property of monomeric p53 as results with both monomeric p53 mutants (deletion and point mutant) were similar. As a negative control we used the His175 point mutant, which did not activate reporter gene at any concentration (data not shown).
The expression vector pCG contains strong eukaryotic promoter (cytomegalovirus immediate early promoter) able to bind cellular proteins essential for transcription. Therefore one could argue that high amount of pCG vector itself can be responsible for repression of transcription from other promoters. However, since all p53 proteins were expressed from the same type of vector, the results from CAT assays with D324 ± 355 and 1262 proteins show that decrease of CAT activity by wt and DI proteins is not caused by high level of pCG plasmid itself. While wt and DI proteins can activate reporter gene already at very low concentrations (1 and 10 ng of expression plasmid), monomeric p53 mutants D324 ± 355 and 1262 had no detectable activation at less than 100 ng of expression plasmid used. It can re¯ect the decreased DNA binding activity of monomeric proteins.
To be sure that all p53 mutants were expressed at comparable levels and cover the same ranges of concentrations we de®ned the relative amount of p53 in all lysates used for CAT assays. Transfected cells were collected 24 h after transfection and divided between two tubes. Half of cells was lysed for CAT assay, the second half was lysed for Western blotting directly in SDS loading buer. All protein lysates were separated in SDS ± PAGE at the same time and transferred to the same piece of PVDF membrane. The membrane was incubated with mixture of primary antibodies against p53 (pAb1801 and pAb240) and against TBP (3G3). After incubation with biotinylated secondary antibody and avidin-FITC,¯uorescent signal was quantitated with FluorImager and ImageQuaNT software. 43 kD band of TBP can be easily separated from p53 bands and was used as internal standard for determination of total amount of protein.
Ratio between signals from p53 and TBP bands was further divided with percentage of transfection eciency of particular series of transfection. Result is given on Figure 3 and re¯ects ratio between signals of p53 and TBP bands per transfected cell. This result can be used only for comparison of protein amount on dierent lanes of the same blot and can not be interpreted as intracellular molar ratio between p53 and TBP, because the latter depends on concentration and anity of dierent antibodies. As seen on Figure  3 , the same amount of expression plasmid produced roughly the same amount of dierent p53 proteins and amount of each protein correlated with amount of expression plasmid used in transfections. Exception was DI, which had higher steady-state level at every concentration point. Diminished degradation can be reason for elevated level of DI protein, which has been cDNA-s were cloned between XbaI and BglII sites of eukaryotic expression vector pCG (Tanaka and Herr, 1990) . DI encodes p53 with deletion in the ®rst conserved domain of p53 (amino acids 13 ± 19). For creating D324 ± 355, two regions of wt p53 cDNA were ampli®ed: one between codons 1 and 323 and another between codons 356 and 393. Resulting cDNA-s were linked in frame to each other from PstI site designed into PCR primers.
Half of PstI site (CAG) encodes an extra amino acid (Glu) between these two regions. 1262 contains four point mutations in oligomerization domain and is described previously (Tarunina and Jenkins, 1993) . (b) Oligomerization of p53 mutants. Cells transfected with 2 mg of p53 expression plasmids, were lysed in IP buer (500 mM NaCl, 50 mM Hepes pH 7.5, 1 mM EDTA, 0.5% NP40) and crosslinked with dierent concentrations of glutaraldehyde. Protein complexes were separated in 6% SDS ± PAAG, transferred to nitrocellulose ®lter and blotted with mixture of antibodies pAb240 and pAb1801. Concentration of glutaraldehyde (GA) is indicated on top of lanes. Bands corresponding to mono-, di-and tetramers are indicated on left side (1, 2 and 4, respectively)
p53 oligomerization and inhibition of transactivation A Kristjuhan et al shown to be resistant to MDM2-directed degradation and is more stable when expressed in cells . Quantitation of proteins also shows that weak activation of reporter gene by DI is not caused by lack of protein expression.
To test whether changes in speci®c DNA binding activity of p53 are responsible for loss of transactivation at high expression level, we tested the DNAbinding properties of wt p53 expressed at dierent concentrations. As seen on Figure 4 , amount of speci®c DNA bound to wt p53 correlates with amount of p53 expression plasmid used in transfections indicating that low transactivating activity of p53 is not caused merely by low proportion of functional protein in the pool (compare CAT activity on Figure 2a and DNA-binding activity on Figure 4 lines 1 to 6). Retarded band seen on Figure 4 is speci®c to p53 because it can be titrated out with 25-fold molar excess of unlabelled CON site but not with nonspeci®c oligonucleotide (Figure 4 , lines 6 to 8). It also can be supershifted with pAb1801 antibody reacting with N-terminus of p53 but not with pAb419 antibody directed against SV40 large T antigen (Figure 4 , lines 4, 9, 10). pAb1801 does not produce any bands when cell lysate does not contain p53 (Figure 4, line 11) .
Previous studies have shown that expression level can be a factor modulating the transactivating properties of p53. p53 accumulates eciently after U.V. induction in mouse NIH3T3 and T22 cells. It has, however, been demonstrated that there is a discordance between the transcriptional activity of p53 and its protein level: expression of p53 target genes is induced only in cells, which contain moderate level of p53 protein and no gene expression is observed at high protein concentration (Lu et al., 1996) . We have shown with reporter systems that the transactivation capability of wt p53 is strongly inhibited by high protein . It has p53 consensus DNA-binding site CON (Funk et al., 1992) and modi®ed adenovirus E2 promoter in front of chloramphenicol acetyltransferase gene. Eciency of transfection was determined by parallel transfection with b-galactosidase expression plasmid pON260 (Spaete and Mocarski, 1985) p53 oligomerization and inhibition of transactivation A Kristjuhan et al concentration in the cells (Kristjuhan and Maimets, 1995) . In this study we speci®ed the structural requirements of this ®nding. We showed that oligomerization of p53 protein is needed for loss of transactivation at high p53 concentrations. The highest transactivating activity of oligomerization-competent wt and DI proteins was observed at relatively low concentrations of p53 protein. Increasing p53 concentration causes inhibition of transactivation when compared with lower protein amounts. This eect was not observed with monomeric p53 proteins. We also tested p53 mutant 517 (Tarunina and Jenkins, 1993) , which forms preferably dimers but also higher oligomers in solution (StuÈ rzbecher et al., 1992) . The level and dynamics of transactivation by 517 was the same as with wt p53 (data not shown). We conclude that oligomerization of p53 is important to suppress transactivation at high concentrations.
Mechanism of transactivation by p53 is most likely based on interactions with proteins of the basal transcription machinery. To date it has been shown that p53 interacts with TFIIH and TFIID complexes (Liu et al., 1993; Xiao et al., 1994) , with TBP (Martin et al., 1993; Seto et al., 1992; Truant et al., 1993) , TBP associated proteins TAF II 60 and TAF II 40 from Drosophila cells (Thut et al., 1995) , and with human analogue of Drosophila TAF II 40, TAF II 31 (Lu and Levine, 1995) . At overexpression conditions, activator proteins could titrate out some basal transcription factors, amount of which is limited in the cell. This phenomenon is known as squelching (Ptashne, 1988) . At optimal concentrations, every activator molecule bound to the test promoter, is also bound to the target molecule(s) (for example TFIID complex). In excess of the activator, most of activator proteins bound to the test promoter are not bound to the target molecule(s) because of limited amount of the latter. Therefore, activation of the test promoter is inhibited as compared to the optimal concentration of activator. In the case of p53, in vitro experiments have shown that TFIID complex and TFIIB protein are the limiting factors, which can be titrated out by excess amounts of p53 (Liu and Berk, 1995) . It is therefore possible that inhibition of transactivation by wt and DI proteins at high concentrations is caused by squelching of some basal transcription factors. On the other hand, high levels of monomeric mutants D324 ± 355 and 1262 did not cause the eect of squelching. Columns show the average value, error bars indicate standard error. Cells were lysed 24 h after transfection in SDS loading buer (50 mM Tris-HCl pH 6.8; 100 mM DTT; 2% SDS; 0.1% bromophenol blue; 10% glycerol) and boiled for 10 min. Lysate was separated by SDS ± PAGE in 10% gel. Proteins were transferred to BioBlot-PVDF membrane (`Costar'). Free surface of the ®lter was blocked for 10 min at RT with 1% non-fat milk powder in PBS+0.05% Tween 20. Membrane was incubated with monoclonal antibodies 3G3, pAb1801 and pAb240 in blocking solution for 2 h at RT. After washing with PBS+Tween 20, ®lter was incubated for 1 h at RT with biotinylated secondary antibody against mouse Ig. Finally, the membrane was incubated with streptavidin-FITC. Quantitation of data was performed with FlourImager and ImageQuaNT software (`Molecular Dynamics') 0 1 10 100 1000 5000 5000 5000 100 100 0 1 2 3 4 5 6 7 8 9 10 11
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Figure 4 DNA binding activity of wt p53 at dierent concentrations. Lysates from cells transfected with dierent amounts of pCG-Hwt were incubated with 2 ng of radiolabeled CON site in buer containing 20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM MgCl 2 , 0.1% NP40, 5% sucrose, 200 ng herring sperm DNA and 2 ml pAb421 supernatant. Amount of expression plasmid used for transfection is indicated on top of lanes. 50 ng of unlabeled CON site or nonspeci®c ds-oligonucleotide was added to reactions on lanes 7 or 8, respectively. Five ml of pAb1801 or pAb419 supernatant was added as indicated. Protein-DNA complexes were separated in 5% TBE polyacrylamide gel and exposed to X-ray ®lm p53 oligomerization and inhibition of transactivation A Kristjuhan et al
One possible explanation here is that monomeric p53 can not interact with transcription machinery at all and therefore it can not squelch basal transcription factors. Analogously, oligomeric state of p53 is needed for interaction with MDM2 (Marston et al., 1995) . Although speci®c complex between DNA and monomeric p53 is poorly detectable in cell lysate, puri®ed p53 monomers are capable to bind cooperatively to consensus DNA (Balagurumoorthy et al., 1995; Wang et al., 1995) . p53 binding DNA consensus sequence contains two tandem decameric elements, each containing two pentameric inverted repeats. Therefore, the DNA itself can be a factor, which brings four p53 monomers together and p53 could gain the ability to interact with transcription machinery only after binding to the DNA consensus sequence. Increasing concentration of monomeric p53 in the cell could increase probability that more test promoters are bound to multiple p53 monomers, which in turn assures higher transcription eciency from the promoter.
In this paper we have shown that the ability of p53 to activate transcription may be regulated by its state of oligomerization. In that sense, p53 is similar to another transcription factor, Drosophila protein KruÈ ppel (Kr). Monomeric Kr can act as a transcriptional activator, whereas Kr oligomers formed at high concentrations cause repression. Interactions with dierent parts of transcriptional machinery are responsible for these eects. (Sauer et al., 1995) .
